BioWorld Asia

May 7, 2003

European Sector Experiences Falloff In Revenues, Employees

LONDON - The European biotechnology sector in 2002 saw revenues and employee numbers fall for the first time in a decade, according to Ernst & Young's 10th annual survey of the sector. (BioWorld International) Read More

Phytopharm Enters Potentially Lucrative Deal With Yamanouchi

Estrogen Receptor Modulators May Have Anticancer Role, Study Shows

Vernalis Raising £14.1 Million As It Negotiates Sale Of Company

Israeli Biotech Continues Growth With Private, Government Support

Irish University-Industry Program Draws Funding, Foreign Partners

Serono Disagrees With Rejection Of Serostim For AIDS Wasting

Protherics Paying £17.9M In Notes, Shares For Acquisition Of Enact

Zealand, Wyeth Collaborate On Gap Junction Modulators

Hybrigenics Acquires Dutch Firm Semaia In 'Friendly' Stock Deal

Sloning Raises EUR4.3M In Second Round For DNA Cloning Program

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 9, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

Development and characterization of anti-CD19 in vivo CAR T therapy

BioWorld Science

Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...

Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome

BioWorld Science

The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...